The dose-effect relationship in extracorporeal shock wave therapy: The optimal parameter for extracorporeal shock wave therapy

Journal of Surgical Research

Volumn 186, Issue 1, 2014, Pages 484-492

  Zhang, Xiongliang ^a   Yan, Xiaoyu ^a   Wang, Chunyang ^a   Tang, Tingting ^b   Chai, Yimin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiogenic factors; Apoptotic factors; Chemotactic factors; Dose effect relationship; Endothelial progenitor cells; Extracorporeal shock wave therapy; Inflammation factors; Ischemia disease; Optimal parameter

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; AUTACOID; CASPASE 3; CHEMOKINE RECEPTOR CCR4; CHEMOTACTIC FACTOR; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL 2; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CELL VIABILITY; DOSE RESPONSE; ENDOTHELIAL PROGENITOR CELL; EXTRACORPOREAL LITHOTRIPSY; GENE SEQUENCE; MALE; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ANGIOGENIC FACTORS; APOPTOTIC FACTORS; CHEMOTACTIC FACTORS; DOSE-EFFECT RELATIONSHIP; ENDOTHELIAL PROGENITOR CELLS; EXTRACORPOREAL SHOCK WAVE THERAPY; INFLAMMATION FACTORS; ISCHEMIA DISEASE; OPTIMAL PARAMETER;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CHEMOTACTIC FACTORS; ENDOTHELIAL CELLS; HIGH-ENERGY SHOCK WAVES; INFLAMMATION MEDIATORS; ISCHEMIA; MALE; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 84890123311     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.08.013     Document Type: Article

References (43)

1. S.K. Shrivastava, and Kailash Shock wave treatment in medicine J Biosci 30 2005 269
2. C.J. Wang Extracorporeal shockwave therapy in musculoskeletal disorders J Orthopaedic Surg Res 7 2012 11
3. Y. Wang, T. Guo, and H.Y. Cai Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease Clin Cardiol 33 2010 693
4. Y. Ito, K. Ito, T. Shiroto, and R. Tsuburaya Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo Coron Artery Dis 21 2010 304
5. G. Yang, C. Luo, X. Yan, L. Cheng, and Y. Chai Extracorporeal shock wave treatment improves incisional wound healing in diabetic rats Tohoku J Exp Med 225 2011 285
6. X. Yan, B. Zeng, Y. Chai, C. Luo, and X. Li Improvement of blood flow, expression of nitric oxide, and vascular endothelial growth factor by low-energy shockwave therapy in random-pattern skin flap model Ann Plast Surg 61 2008 646
7. K. Ito, Y. Fukumoto, and H. Shimokawa Extracorporeal shock wave therapy as a new and non-invasive angiogenic strategy Tohoku J Exp Med 219 2009 1
8. H.K. Yip, L.T. Chang, C.K. Sun, A.A. Youssef, J.J. Sheu, and C.J. Wang Shock wave therapy applied to rat bone marrow-derived mononuclear cells enhances formation of cells stained positive for CD31 and vascular endothelial growth factor Circ J Off J Jpn Circ Soc 72 2008 150
9. K.H. Yeh, J.J. Sheu, and Y.C. Lin Benefit of combined extracorporeal shock wave and bone marrow-derived endothelial progenitor cells in protection against critical limb ischemia in rats Crit Care Med 40 2012 169
10. D.W. Li, Z.Q. Liu, J. Wei, Y. Liu, and L.S. Hu Contribution of endothelial progenitor cells to neovascularization (review) Int J Mol Med 30 2012 1000
11. T. Asahara, H. Masuda, and T. Takahashi Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ Res 85 1999 221
12. J.P. Kirton, and Q. Xu Endothelial precursors in vascular repair Microvasc Res 79 2010 193
13. I. Kanzler, N. Tuchscheerer, and G. Steffens Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis Basic Res Cardiol 108 2013 310
14. C. Alev, M. Ii, and T. Asahara Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases Antioxid Redox Signal 15 2011 949
15. C.K. Sun, L.T. Chang, and J.J. Sheu Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy Crit Care Med 37 2009 1197
16. M.C. Yoder, L.E. Mead, and D. Prater Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals Blood 109 2007 1801
17. N. Yang, D. Li, and P. Jiao The characteristics of endothelial progenitor cells derived from mononuclear cells of rat bone marrow in different culture conditions Cytotechnology 63 2011 217
18. D.A. Ingram, L.E. Mead, and H. Tanaka Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood Blood 104 2004 2752
19. M.A. Reichenberger, H. Keil, and W. Mueller Comparison of extracorporal shock wave pretreatment to classic surgical delay in a random pattern skin flap model Plast Reconstr Surg 127 2011 1830
20. M.A. Reichenberger, S. Heimer, and A. Schaefer Extracorporeal shock wave treatment protects skin flaps against ischemia-reperfusion injury Injury 43 2012 374
21. F. Kamelger, M. Oehlbauer, H. Piza-Katzer, and R. Meirer Extracorporeal shock wave treatment in ischemic tissues: what is the appropriate number of shock wave impulses? J Reconstr Microsurg 26 2010 117
22. M.A. Reichenberger, G. Germann, H.J. Roth, R. Meirer, and H. Engel Preoperative shock wave therapy reduces ischemic necrosis in an epigastric skin flap model Ann Plast Surg 63 2009 682
23. R. Mittermayr, J. Hartinger, and V. Antonic Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis Ann Surg 253 2011 1024
24. P.L. Shao, C.C. Chiu, and C.M. Yuen Shock wave therapy effectively attenuates inflammation in rat carotid artery following endothelial denudation by balloon catheter Cardiology 115 2010 130
25. Y. Kikuchi, K. Ito, and Y. Ito Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris Circ J Off J Jpn Circ Soc 74 2010 589
26. S.R. Zins, M.F. Amare, D.K. Tadaki, E.A. Elster, and T.A. Davis Comparative analysis of angiogenic gene expression in normal and impaired wound healing in diabetic mice: effects of extracorporeal shock wave therapy Angiogenesis 13 2010 293
27. A.A. Qureshi, K.M. Ross, R. Ogawa, and D.P. Orgill Shock wave therapy in wound healing Plast Reconstr Surg 128 2011 721e
28. L. Krokowicz, M. Mielniczuk, M. Drews, and M. Siemionow Long-term follow up of the effects of extracorporeal shockwave therapy (ESWT) on microcirculation in a denervated muscle flap Pol Przegl Chir 83 2011 325
29. A. Stojadinovic, E.A. Elster, and K. Anam Angiogenic response to extracorporeal shock wave treatment in murine skin isografts Angiogenesis 11 2008 369
30. K. Oi, Y. Fukumoto, and K. Ito Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits Tohoku J Exp Med 214 2008 151
31. R. Meirer, G.M. Huemer, M. Oehlbauer, S. Wanner, H. Piza-Katzer, and F.S. Kamelger Comparison of the effectiveness of gene therapy with vascular endothelial growth factor or shock wave therapy to reduce ischaemic necrosis in an epigastric skin flap model in rats J Plast Reconstr Aesthet Surg 60 2007 266
32. A. Aicher, C. Heeschen, and C. Mildner-Rihm Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells Nat Med 9 2003 1370
33. Q.X. Zhang, C.J. Magovern, C.A. Mack, K.T. Budenbender, W. Ko, and T.K. Rosengart Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis J Surg Res 67 1997 147
34. Y. Fujihara, H. Koyama, N. Nishiyama, T. Eguchi, and T. Takato Gene transfer of bFGF to recipient bed improves survival of ischemic skin flap Br J Plast Surg 58 2005 511
35. A. Beenken, and M. Mohammadi The FGF family: biology, pathophysiology and therapy Nat Rev Drug Discov 8 2009 235
36. Y.R. Kuo, W.S. Wu, and Y.L. Hsieh Extracorporeal shock wave enhanced extended skin flap tissue survival via increase of topical blood perfusion and associated with suppression of tissue pro-inflammation J Surg Res 143 2007 385
37. B. Witzenbichler, P.C. Maisonpierre, P. Jones, G.D. Yancopoulos, and J.M. Isner Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2 J Biol Chem 273 1998 18514
38. M. Felcht, R. Luck, and A. Schering Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling J Clin Invest 122 2012 1991
39. S. Jesmin, T. Wada, S. Gando, S.S. Sultana, and S. Zaedi The dynamics of angiogenic factors and their soluble receptors in relation to organ dysfunction in disseminated intravascular coagulation associated with sepsis Inflammation 36 2013 186
40. C.C. Khoury, and F.N. Ziyadeh Angiogenic factors Contrib Nephrol 170 2011 83
41. A. Aicher, C. Heeschen, K. Sasaki, C. Urbich, A.M. Zeiher, and S. Dimmeler Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia Circulation 114 2006 2823
42. Y.R. Zou, A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development Nature 393 1998 595
43. M. Calcagni, F. Chen, and D.C. Högger Microvascular response to shock wave application in striated skin muscle J Surg Res 171 2011 347